Conversely, patients with lung cancer exhibiting lower CXCL5 expression displayed less CD66b+ neutrophil infiltration, greater CD8+ T cell infiltration, and lower levels of p-PXN, PD-L1, GM-CSF, PD-1, and TIM-3 expressions. The gene discussed is CSF2; the disease is lung carcinoma.